MIR3129

Across TCGA pan-cancer cohorts, MIR3129 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR3129’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR3129 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3129 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

STAD, LUSC, and THCA are the cancer types where MIR3129 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3129 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	IV	+2.145	<.001	5	view →
LUSC	Male	All	+0.246	.029	2	view →
THCA	All	All	−0.131	.010	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR3129–STAD

Open the STAD breakdown →